Showing results (291-300 of 352) with videos related to
Sort By:
Pageof 36
Spine|September 22, 2025
The Impact of Age on Patient Reported Outcome Measures after Posterior Cervical Decompression and FusionJonathan Dalton, Jarod Olson, Rachel Huang, et al.Haematologica|July 22, 2017
Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndromeNaval Daver, Hagop Kantarjian, Guillermo Garcia-Manero, et al.The Lancet. Oncology|December 8, 2016
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control studyKoichi Takahashi, Feng Wang, Hagop Kantarjian, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsFunda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.JCO Precision Oncology|May 17, 2023
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class RearrangementsJayastu Senapati, Elias Jabbour, Marina Konopleva, et al.Journal of Gastroenterology and Hepatology|March 18, 2011
Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patientsKeyur Patel, Alexander J Thompson, Wan-Long Chuang, et al.Atherosclerosis|July 22, 2017
Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomesAyman Samman Tahhan, Salim S Hayek, Pratik Sandesara, et al.Journal of the American Heart Association|December 22, 2017
Marital Status and Outcomes in Patients With Cardiovascular DiseaseWilliam M Schultz, Salim S Hayek, Ayman Samman Tahhan, et al.American Journal of Hematology|January 5, 2017
Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantationSameh Gaballa, Rima Saliba, Betul Oran, et al.American Journal of Hematology|June 26, 2019
Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenibFevzi Yalniz, Iman Abou Dalle, Hagop Kantarjian, et al.Pageof 36